Oncology

ImmunotherapeuticsimmunotherapyMedical NewsOncologyPublic health

Combo Immunotherapy Outperforms Monotherapy in Cancer Trial NSCLC

Translational findings and higher major pathological response support combinations over monotherapy before surgery for Non-Small Cell Lung Cancer From University ...
CancerCorporate negligenceHealthOncology

J&J Forms Subsidiary to Resolve Talc Claims, It Files for ...

Johnson & Johnson (J&J) Corporate negligence Johnson & Johnson (J&J) announced that LTL Management LLC (LTL), a newly created and ...
CancerImmunology studiesImmunotherapeuticsimmunotherapyMedical NewsOncology

Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C ...

News Release 18-Sep-2021 Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma ESMO Congress 2021, 16-21 September Reports ...